Pharmaversity®

Medication errors and shortages of drugs are some of the most urgent issues at hospitals. The WHO estimates the total global costs of medication errors are 42 Billion USD per year. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures and are becoming more frequent globally.
This session will explore how polymer pre-fillable syringes can help hospital pharmacies and compounding centers to reduce drug shortages and save costs for hospitals and health care system while increasing patient safety.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Standard pharmaceutical bulk fill-and-finish processes can introduce various damages to containers starting from cosmetic defects (as scratches or abrasions) to occasional glass breakage, leading to rejects and disruptions during manufacturing. We also cover an introduction to our EVERIC® strong module that shows how the inherent strength of a vial can be increased by optimizing the geometry with in the ISO tolerances. EVERIC® smooth is one part of SCHOTT’s new modular vial concept, comprising an outer coating that aims to improve the overall processing performance on bulk production lines. In this webinar, the results of a comparative filling line trial with EVERIC® smooth vials at F. Hoffmann-La Roche will be presented.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Cracking or breakage of primary packaging glass containers is an annoying incidence that can cause numerous unpleasant consequences, such as down time of fill & finish lines, vendor and customer complaints, right up to market recalls. In most cases, cracking or breakage of glass is the result of improper handling or processing and/or excessive mechanical loading. To better understand the mechanical strength of glass as primary packaging container, this webinar will cover the fundamental concepts of brittle failure with respect to the circumstances and conditions of the pharmaceutical industry.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Pre-filled syringes made of high-quality Cyclic Olefin Copolymer (COC) have become a well-established alternative for administering drugs. Due to its properties and manufacturing process, COC is heavy metal and tungsten free and also exhibits low or no siliconization. However, the polymer also has a different E&L profile and a lower oxygen and gas barrier threshold than borosilicate glass, which increases the potential for drug interaction. These barrier properties are of concern when it comes to labeling. As adhesive labels are affixed directly to the container, there is a potential risk of adhesive migration into the polymer. This can be overcome by using functional labels, which even have the potential to enhance the primary packaging by adding specific functionalities –from overt or covert as well as analog and digital security features to effective first-opening indication - or specific protection through UV-blocking or enhanced gas barrier properties.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fill & Finish is the core of the pharmaceutical industry. Any interference of the production process causes trouble in delivering the drug on time in a flexible and easy way. For this, it is indispensable to know what is happening on production lines and what impact they have on primary packaging. Data can be a valuable source of gaining insights on the performance of lines as well as a helpful result of “pain points” of lines and primary packaging containers. SmartSkin provides drones for pressure management on filling and packaging lines. With the strong cooperation between SCHOTT & SmartSkin you can optimize the fill & finish performance to reduce glass breakage, bruising and micro fractures.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Advances in cryopreservation lead to new challenges in the field of pharmaceutical packaging. While it keeps the drug in a stable state, allows for longer shelf life, and ensures stability throughout the supply chain, manufacturers must plan for the unique challenges for vial-based container closure systems. In this session, our experts will share their study results in regards to container closure integrity at cryo temperatures.

Learn more about your ad choices. Visit megaphone.fm/adchoices

This session addresses the market trend to individualizing primary packaging containers to the requirements of different drug formulations. Here, we show results (from studies of controlling delamination even) of stability studies of relevant biologic buffers and Water-for-injection with low-filling volumes in vials. A comparative study with standard vials will explain outstanding results.

Learn more about your ad choices. Visit megaphone.fm/adchoices